Overview

Post Marketing Study to Evaluate the Efficacy and Safety of Micafungin Treatment on Invasive Aspergillosis

Status:
Terminated
Trial end date:
2015-06-26
Target enrollment:
Participant gender:
Summary
The objective of this study is to evaluate the efficacy and safety of intravenous micafungin for the treatment of proven or probable fungal infections caused by Aspergillus sp. (Fungemia, respiratory mycosis, gastrointestinal mycosis) in adult patients in China.
Phase:
Phase 4
Details
Lead Sponsor:
Astellas Pharma China, Inc.
Treatments:
Echinocandins
Micafungin